Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotinylated geldanamycin.

Randell C Clevenger1, Joseph M Raibel, Angela M Peck

  • 1Department of Medicinal Chemistry and The Center for Protein Structure and Function, The University of Kansas, 1251 Wescoe Hall Dr, Malott Hall 4070, Lawrence, Kansas 66045-7564, USA.

The Journal of Organic Chemistry
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attempts to Achieve Targeted Covalent Inhibition of Hsp90β.

Chemical biology & drug design·2026
Same author

Cell-Impermeable Hsp90α-Selective Inhibitor NDNA4 Inhibits Cancer Cell Migration and Targets Extracellular Hsp90α's Critical F-5 Fragment.

ACS chemical biology·2026
Same author

The evolution of heat shock protein 90 C-terminal inhibitors: From novobiocin to potential clinical candidates.

Cell stress & chaperones·2026
Same author

Optimization of triazole-based small molecule disruptors of the Aha1/Hsp90 complex that manifest potent activities.

European journal of medicinal chemistry·2026
Same author

Small Molecules to Elevate Rab7-GTPase Activity and Lower Cholesterol Accumulation in Niemann-Pick Type C Disease.

Pharmaceutical research·2026
Same author

Multi-omic integration identifies broad drug resistance mechanisms and strategies to therapeutically reprogram cancer cells.

iScience·2026

Researchers synthesized biotinylated geldanamycin (GDA) analogues to identify proteins that bind GDA, potentially causing side effects. This approach aims to discover selective Hsp90 inhibitors for cancer therapy by revealing off-target protein interactions.

Area of Science:

  • Oncology
  • Biochemistry
  • Drug Discovery

Background:

  • Heat shock protein 90 (Hsp90) is a crucial target for cancer chemotherapy.
  • Ansamycin antibiotics, like geldanamycin (GDA), inhibit Hsp90 function by binding to its ATP domain.
  • Identifying off-target interactions of GDA is essential for developing selective inhibitors.

Purpose of the Study:

  • To synthesize biotinylated analogues of GDA to identify other proteins that bind GDA.
  • To develop complementary methods for isolating GDA-bound proteins.

Main Methods:

  • Synthesis of biotinylated GDA analogues with varying tether lengths.
  • Use of photolabile tethers for protein removal from affinity resins.
  • Affinity purification using neutravidin-containing resin.

Related Experiment Videos

Main Results:

  • Preliminary studies successfully isolated several proteins using biotinylated GDA.
  • These isolated proteins include targets other than Hsp90, indicating potential off-target binding.

Conclusions:

  • Biotinylated GDA analogues are effective tools for identifying novel protein interactions.
  • This method aids in the discovery of selective Hsp90 inhibitors and understanding potential side effects of GDA-based cancer therapies.